Oppenheimer & CO Inc Insulet Corp Transaction History

Oppenheimer & CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$272.48 - $330.23 $108,992 - $132,092	400 Added 21.36%	2,273 $655,000
Q1 2023 May 10, 2023	SELL	$276.36 - $326.03 $27,636 - $32,602	-100 Reduced 5.07%	1,873 $597,000
Q4 2022 Feb 07, 2023	BUY	$212.22 - $313.46 $418,710 - $618,456	1,973 New	1,973 $580,000
Q1 2022 May 12, 2022	SELL	$194.8 - $275.7 $168,307 - $238,204	-864 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$255.32 - $318.29 $3,574 - $4,456	14 Added 1.65%	864 $230,000
Q3 2021 Nov 12, 2021	BUY	$260.36 - $307.27 $221,306 - $261,179	850 New	850 $242,000
Q4 2020 Feb 11, 2021	SELL	$215.97 - $265.89 $408,399 - $502,797	-1,891 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$192.55 - $236.59 $364,112 - $447,391	1,891 New	1,891 $447,000
Q4 2019 Feb 07, 2020	SELL	$144.81 - $186.0 $257,472 - $330,708	-1,778 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$117.35 - $167.95 $208,648 - $298,615	1,778 New	1,778 $293,000

687

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.